search reports
Categories
Categories

2016-2020 World Influenza Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
Report Code : vpid16250 | Publisher : VPG Market Research
Published Date : 02 March, 2016 | No of Pages: 232

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports
The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Influenza tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 232 pages and 15 tables


I. Introduction
II. Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
0 Abbott AxSYM
0 Abbott IMx/IMx Select
0 Anagen AN2000/AuraFlex
0 Beckman Coulter Access
0 BioChem Pharma/SR1
0 BioMerieux/Vitek Vidas
0 Biotrol System 7000
0 Chiron ACS: Centaur
0 Chiron ACS: 180
0 J&J Diagnostics/Amersham Amerlite
0 J&J Diagnostics Vitros ECi
0 Olympus PK310
0 Roche Cobas Core
0 Roche Elecsys 1010/2010
0 Roche ES 22
0 Roche ES 33
0 Roche ES 300/300AL
0 Siemens ELISA Processor II/III
0 Siemens Immuno 1
0 Siemens/Opus/Plus/Magnum
0 Siemens Stratus
0 Tosoh AIA-1200/1200DX/NexIA/600
0 Wallac/Pharmacia Delfia
E. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
0 Polymerase Chain Reaction
Table of Contents (continued)
- Robotics
- Temperature Cyclers
- PCR Variations
0 Immuno-PCR
0 QC-PCR
0 DAP-PCR
0 Ligase Chain Reaction
0 Branched DNA
0 Q-Beta Replicase
0 Nucleic-Acid Sequence-Based
0 Strand Displacement Activation
0 Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
0 Overview
0 ELISA
0 Dot Immunobinding Assays
0 Capillary Immunoassays
0 Particle-Membrane Capture Immunoassays
0 Enzyme Amplification
c. Fluorescent Immunoassays
0 Fluorescence Polarization
0 Time-Resolved Pulse Fluorescence
d. Luminescence
0 Chemiluminescence
0 Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers’ Sales
and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
Table of Contents (continued)
V. Italy: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
IX. USA: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
Table of Contents (continued)
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
Table of Contents (continued)
- Wampole Labs
- Zenith
- Zeus
Competitive Assessments - Abbott - ADI/American Diagnostica - Agilent Technologies - Alere/Biosite/Inverness - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Bio-Rad - Cepheid - Chrono-Log - Corgenix - Decode Genetics - Diadexus - Diagnocure - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - Eiken Chemical - EKF Diagnostics - Fujirebio - Grifols - Helena Laboratories - Hologic/Gen-Probe - Horiba - Instrumentation Laboratory - International Technidyne/Nexus DX - Kreatech/Leica - Kyowa Medex - Lonza - Mackay Life Sciences - Matritech - Nihon Kohden - Ortho-Clinical Diagnostics - Polartechnics - Polymedco - Qiagen - Roche - SDIX - Sequenom - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher - Tosoh - Wako - Zycare/Alere
Please select License
Single User Price:$ 4350
Enterprise Price:$ 9500